chr21-33914467-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001697.3(ATP5PO):āc.70T>Cā(p.Phe24Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001697.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP5PO | NM_001697.3 | c.70T>C | p.Phe24Leu | missense_variant | 2/7 | ENST00000290299.7 | NP_001688.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP5PO | ENST00000290299.7 | c.70T>C | p.Phe24Leu | missense_variant | 2/7 | 1 | NM_001697.3 | ENSP00000290299.2 | ||
ENSG00000249209 | ENST00000429238.2 | c.70T>C | p.Phe24Leu | missense_variant | 3/8 | 5 | ENSP00000394107.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000879 AC: 22AN: 250334Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135374
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1460854Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726682
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 28, 2023 | The c.70T>C (p.F24L) alteration is located in exon 2 (coding exon 2) of the ATP5O gene. This alteration results from a T to C substitution at nucleotide position 70, causing the phenylalanine (F) at amino acid position 24 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at